Home » Topics » Science » New compound

New compound
RSS

CDK7 inhibitor GTAEXS-617 shows potent antitumor activity in vivo

May 5, 2022

CRD-1600 demonstrates robust immune modulatory properties in vitro and in vivo

May 4, 2022

GTX-0196 shows complete tumor growth suppression in models of AML

May 4, 2022

Bridge Biotherapeutics and Cyrus Therapeutics generate next-generation EGFR degraders

May 2, 2022

BBT-207, a fourth-generation EGFR TKI with activity against most common mutants

May 2, 2022

AC-0027875, a gamma-secretase modulator for the treatment of AD

April 29, 2022

KSHN-001034, a novel prodrug that delivers higher fulvestrant concentrations

April 28, 2022

ARTS-021 shows promising antitumor activity in CCNE1-amplified cancer models

April 27, 2022

ZLD-2218, a novel BRD4 inhibitor for the treatment of kidney fibrosis

April 26, 2022

CJRS-10671 and CJRS-10672, biotherapeutic candidates with promising antitumor efficacy in vivo

April 25, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...